Views Navigation

Event Views Navigation

Today

Virtual Psychiatry Grand Rounds – Marley Doyle, MD

Marley Doyle, MD talk title TBA   Zoom link Meeting ID: 948 0596 9836 Passcode: 5555   CME Credit information Those viewing Grand Rounds are now responsible for logging their […]

Contingency Management, HIV, and MSM: Current Status

Our #VCBHLectureSeries is back! We are thrilled to kick off the FY23 season with guest speaker, Steven Shoptaw, PhD, Executive Director of the Center for Behavioral and Addiction Medicine at UCLA. He […]

What has Brain Imaging Taught us about Addiction?

Edythe London, PhD will be joining us to discuss how the imaging of brain structure, chemistry and function is possible using noninvasive techniques that have been applied to the study […]

The Neurobiology of Addiction

Presenter: Steven Straubing, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. This discussion is designed to promote […]

Tobacco Regulations Across the Continuum of Harm

Tracy Smith, PhD Assistant Professor of Psychiatry and Behavioral Services Medical University of South Carolina   The VCBH Monthly Lecture Series was originally created as an in-person series designed as […]

Alcohol Use Disorder (FAME Session #3)

Presenters: Abby Letcher, MD, FASAM; Angela Colistra, PhD, LPC, CAADC, CCS; Shanna Diaz, DO Series: This 2-hour, virtual-live session is part of the FAME 8-session series and will cover overdose prevention […]

The Connection Between Mental Health and Opioid Use Disorder

Presenter: Mark Duncan, MD, Assistant Professor, University of Washington, Director, UW Psychiatry and Addictions Case Conference Sponsor: American Psychiatric Association (APA) Cost: No Fee Target audience: Physicians, nurse practitioners or other advanced […]

Illicit Drug Supply: Fentanyl and Xylazine

Presenter: Richard Dawson, PhD, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry This presentation will explore current […]

Substance Use Disorders in Late Life

Register Now   Presenters: Roberto D. Sanchez, DO and Ali Abbas Asghar-Ali, MD Target Audience: This activity is designed for Psychiatrists, Physicians, Physician Assistants, Nurses/Nurse Practitioners, Social Workers, Psychologists, Pharmacists, […]

Nurses’ Practices with People Experiencing Opioid Use Disorder

Register Now   Presenter: Timothy J. Sowicz, PhD, RN Cost: No Fee Target audience: This activity is designed for for Nurses, MAT Team Providers, Addictions Specialists, SUD Project Directors, Managers, and Facilitators. This […]

Treatment Considerations in the Age of Fentanyl

Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems, treatment providers, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. Speakers: - Kathryn Cates-Wessel, CEO, American Academy of Addiction Psychiatry - John J. Mariani, MD, Associate Professor […]

Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain, Opioid Misuse, and Opioid Use Disorder

Register Now   Presenter: Eric Garland, PhD, LCSW Sponsoring organization: American Society for Pain Management Nursing (ASPMN) Target audience: Clinical providers including Physicians, PAs and NPs About the webinar: Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a […]

Initiating Buprenorphine for Patients Using Fentanyl

Register Now Presenter: Brian Hurley, MD, MBA, DFASAM, FAPA Cost: No Fee Target audience: Nurses, Addictions Specialists, SUD Project Directors, Managers, and Facilitators and MOUD (medications for opioid use disorder) providers Credit Designations Available: Nursing CE Webinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The […]

Xylazine and How it Harms People Who Use Drugs

Register now! Presenters: Raagini Jawa, MD Cost: No fee Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. Description: We will review what is known to date on Xylazine, a CNS depressant, which has been linked to an increasing number of overdose deaths in the US. This […]